MENU
+Compare
NUS
Stock ticker: NYSE
AS OF
Dec 18, 03:42 PM (EDT)
Price
$7.13
Change
-$0.19 (-2.60%)
Capitalization
666.19M

NUS NuSkin Enterprises Forecast, Technical & Fundamental Analysis

a developer of personal care products and nutritional supplements

NUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for NUS with price predictions
Dec 17, 2024

NUS in upward trend: price rose above 50-day moving average on November 11, 2024

NUS moved above its 50-day moving average on November 11, 2024 date and that indicates a change from a downward trend to an upward trend. In of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for NUS crossed bullishly above the 50-day moving average on November 14, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NUS advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where NUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for NUS moved out of overbought territory on November 19, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 16, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on NUS as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NUS turned negative on December 11, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NUS broke above its upper Bollinger Band on November 11, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.811) is normal, around the industry mean (16.934). P/E Ratio (79.294) is within average values for comparable stocks, (201.433). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.832). Dividend Yield (0.091) settles around the average of (0.107) among similar stocks. P/S Ratio (0.341) is also within normal values, averaging (113.563).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NUS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

View a ticker or compare two or three
NUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NUS is expected to report earnings to rise 39.53% to 23 cents per share on February 12

NuSkin Enterprises NUS Stock Earnings Reports
Q4'24
Est.
$0.24
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.04
Q4'23
Beat
by $0.18
The last earnings report on November 07 showed earnings per share of 17 cents, missing the estimate of 20 cents. With 49.98K shares outstanding, the current market capitalization sits at 666.19M.
A.I.Advisor
published Dividends

NUS paid dividends on December 11, 2024

NuSkin Enterprises NUS Stock Dividends
А dividend of $0.06 per share was paid with a record date of December 11, 2024, and an ex-dividend date of November 29, 2024. Read more...
A.I. Advisor
published General Information

General Information

a developer of personal care products and nutritional supplements

Industry HouseholdPersonalCare

Profile
Fundamentals
Details
Industry
Household Or Personal Care
Address
75 West Center Street
Phone
+1 801 345-1000
Employees
15200
Web
https://www.nuskin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMANX69.39-0.21
-0.30%
Amana Income Investor
PLSAX29.86-0.12
-0.40%
Principal Large Cap S&P 500 Index A
AMTOX8.85-0.06
-0.67%
AB All Market Real Return 1
TRSYX16.32-0.19
-1.15%
T. Rowe Price Small-Cap Index
RYRRX56.29-0.67
-1.18%
Rydex Russell 2000 A

NUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUS has been loosely correlated with EPC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NUS jumps, then EPC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUS
1D Price
Change %
NUS100%
-0.68%
EPC - NUS
35%
Loosely correlated
-1.10%
HELE - NUS
31%
Poorly correlated
-0.79%
SPB - NUS
27%
Poorly correlated
-0.37%
NWL - NUS
27%
Poorly correlated
-3.14%
CLX - NUS
25%
Poorly correlated
-0.66%
More